Malignant lymphomas in the elderly

Clinics in Geriatric Medicine

Volumn 13, Issue 2, 1997, Pages 251-263

  O'Reilly, S E ^a   Connors, J M ^a   Macpherson, N ^a   Klasa, R ^a   Hoskins, P ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BLEOMYCIN; CIMETIDINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; KETOCONAZOLE; METHOTREXATE; MITOXANTRONE; PREDNISONE; VINCRISTINE;

AGED; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; GERIATRIC DISORDER; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PALLIATIVE THERAPY; REVIEW;

EID: 0030958046     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0749-0690(18)30168-x     Document Type: Review

References (29)

1. Balducci L. Pharmacology and organ toxicity of cancer chemotherapy in older patients Oncology 6 1992 62 68
2. Bennett J.M. Andersen J.W. Begg C.B. Age and Hodgkin’s disease: The impact of competing risks and possibly salvage therapy on long-term survival. An ECOG study Leukemia Research 17 1993 825 832
3. Bertini M. Freilone R. Vitolo U. P-VEBEC: A new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin’s lymphoma (NHL) Ann Oncol 5 1994 895 900
4. Carbone P.P. Kaplan H.S. Musshoff K. Reports of the committee on Hodgkin’s disease staging classification Cancer Res 31 1971 1860
5. Chatta G.S. Andrews R.G. Rodger E. Hematopoietic progenitors and aging: Alterations in granulocytic precursors and responsiveness to recombinant human G-CSF, GM-CSF, and IL-3 J Gerontol 48 1993 M207 M212
6. Coltman C.A. Dahlberg S. Jones S.E. CHOP is curative in thirty percent of patients with large cell lymphoma: A twelve year Southwest Oncology Group follow-up Skarin A.T. Update on Treatment for Diffuse Large Cell Lymphoma 1986 John Wiley New York 71 77
7. Connors J.M. Klimo P. Fairey R.N. Brief chemotherapy and involved field radiation therapy for limited stage aggressive histology lymphoma Ann Intern Med 107 1987 25 30
8. Cooper I.A. Wolf M.M. Robertson T.I. Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin’s lymphoma J Clin Oncol 12 1994 769 778
9. Dixon D.O. Neilan B. Jones S.E. Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: The Southwest Oncology Group experience J Clin Oncol 4 1986 295 305
10. Fisher R.I. Gaynor E.R. Dahlberg S. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma New Engl J Med 328 1993 1002 1006
11. Gaynor ER, Dahlberg S, Fisher RI: Factors affecting reduced survival of the elderly with intermediate and high grade lymphoma: An analysis of SWOG-8516 (INT 0067)-The National High Priority Lymphoma Study. A randomized comparison of CHOP versus m-BACOD vs ProMACECytaBOM vs MACOP-B. In Proceedings of the American Society of Clinical Onocology, 1994.
12. Gentleman JF, Hayles P, Kaegi E, et al: Canadian Cancer Statistics. National Cancer Institute of Canada
13. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project:A predictive model for aggressive non-Hodgkin’s lymphoma New Engl J Med 329 1993 987 994
14. McMaster M.L. Johnson D.H. Greeg J.P. A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin’s lymphoma Cancer 67 1991 1487 1492
15. McMaster M.L. Johnson D.H. Greer J.P. A brief duration combination chemotherapy for elderly patients with poor prognosis non-Hodgkin’s lymphoma Cancer 67 1991 1487 1492
16. Miller TP, Dahlberg S, Cassady JR, et al: Three cycles of CHOP plus radiotherapy is superior to eight cycles of CHOP alone for localized intermediate and high grade nonHodgkin’ s lymphoma: A Southwest Oncology Group Study. In Proceedings of the American Society of Clinical Oncology, vol 15, 1996
17. Mir R. Anderson J. Strauchen J. Hodgkin’s disease in patients 60 years of age or older Cancer 71 1982 1857 1866
18. The Non-Hodgkin’s Lymphoma Pathologic Classification Project:National Cancer In-stitute-sponsored study of classification of non-Hodgkin’s lymphomas Cancer 49 1984 2112 2135
19. O’Reilly S.E. Connors J.M. Howdle S. In search of an optimal regimen for elderly patients with advanced-stage diffuse large cell lymphoma: Results of a phase II study of P/DOCE chemotherapy J Clin Oncol 11 1993 2250 2257
20. O’Reilly S.E. Klimo P. Connors J.M. Low-dose ACOP-B and VABE: Weekly chemotherapy for elderly patients with advanced-stage diffuse large cell lymphoma J Clin Oncol 9 1991 741 747
21. Diaz-Pavon Cabanillas F. Malis A. Outcome of Hodgkin’s disease in elderly patients Hematol Oncol 13 1995 19 27
22. Sonneveld P. The treatment of non-Hodgkin’s lymphoma with Mitoxantrone-containing regimens Semin Oncol 1 1995 29 31
23. Sonneveld P. Michiels J.J. Full dose chemotherapy in elderly patients with non-Hodgkin’s lymphoma: A feasibility study using a mitoxantrone containing regimen Br J Cancer 62 1990 105 108
24. Tirelli U. Carbone A. Zagonel V. Non-Hodgkin’s lymphomas in the elderly: Prospective studies with specifically devised chemotherapy regimens in 66 patients Eur J Cancer Clin Oncol 23 1987 535 540
25. Tirelli U. Carbone A. Zagonel V. Non-Hodgkin’s lymphoma in 137 patients aged 70 years or older: A retrospective European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group study J Clin Oncol 6 1988 1708 1713
26. Tirelli U. Zagonel V. Errante D. A prospective study of a new combination chemotherapy regimen in patients older than 70 with unfavorable non-Hodgkin’s lymphoma J Clin Oncol 10 1992 228 236
27. Vose J.M. Armitage J.O. Weisenburger D.D. The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin’s lymphoma J Clin Oncol 6 1988 1838 1844
28. Zagonel V. Babare R. Merola M.C. Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin’s lymphoma treated with combination chemotherapy Ann Oncol 5 1984 S127 S132
29. Zagonel V. Tirelli U. Carbone A. Combination chemotherapy specifically devised for elderly patients with unfavorable Non-Hodgkin’s lymphoma Cancer Investigation 8 1990 577 582